FDA Inspection 1084409 — Reciprocal Labs Corporation

Reciprocal Labs Corporation — FEI 3009637814

The FDA completed an inspection of Reciprocal Labs Corporation on December 13, 2018 in san diego, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 13, 2018
Fiscal Year
2019
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
san diego, CA (United States)